Bristol-Myers Squibb
BMY
#173
Rank
HK$973.39 B
Marketcap
HK$477.98
Share price
-0.33%
Change (1 day)
8.18%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): HK$23.15

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$23.23. In 2024 the company made an earnings per share (EPS) of -HK$34.58 a decrease over its 2023 EPS that were of HK$30.35.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.15-166.96%
2024-HK$34.58-213.92%
2023HK$30.3530.2%
2022HK$23.31-6.04%
2021HK$24.81-179.29%
2020-HK$31.29-281.37%
2019HK$17.25-27.21%
2018HK$23.70
2016HK$20.89175.26%
2015HK$7.59-19.83%
2014HK$9.47-22.44%
2013HK$12.2034.48%
2012HK$9.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.13 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.58 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.64-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.71-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.08 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.10 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.16-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$85.97 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.16 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$41.85 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK